N/A N=60 Motivational Interviewing to Enhance Adherence of Patients With Psychogenic Non-epileptic Seizures
Psychogenic Non-epileptic Seizures, Motivational Interviewing
Primary: Adherence — 9; 17 Participants — p=0.015
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=38 Treatments for Psychogenic Nonepileptic Seizures (NES)
Convulsion, Non-Epileptic · Conversion Disorder · Depression
Primary: Number of Nonepileptic Seizures (NES) — 5.0; 6.0; 3.0; 6.0 seizures — p=0.29
N/A N=10 Treating Non-epileptic Seizures Using Magnetic Brain Stimulation
Nonepileptic Seizures
Primary: Number of Weekly Psychogenic Non-epileptic Seizure-events — 6.9; 5.3 events
N/A N=76 Adherence to and Beliefs on Recommendations for Behavioral Treatment for Migraine
Migraine
Primary: Percentage of Patients Who Made an Appointment for Behavioral Therapy — 37.5; 22.2 percentage of participants
N/A N=168 Motivational Interviews for Depression in Primary Care
Major Depression
Primary: Depression Remission — 4; 15 participants
Phase 3 N=38 Motivational Interviewing to Improve Work Outcomes in Schizophrenia
Schizoaffective Disorder · Schizophrenia
Primary: Obtained Employment — 7; 12; 10; 9 participants — p=.33
N/A N=140 Medication Adherence in Individuals With Epilepsy
Epilepsy
Primary: Raw Count of Number of Days of Medication Nonadherence — 28 % of nonadherence days
N/A N=204 Motivational Interviewing and Neuroimaging With Adolescents
Alcohol Use, Unspecified
Primary: Alcohol-related Problems — 2.75; 4.88 units on a scale — p=.0173
N/A N=30 Neuroimaging Biomarkers of Prognosis in Motor Functional Neurological Disorders
Conversion Disorder
Primary: Gray Matter Volume Biomarkers of 6 Month Prognosis as Measured by Voxel Based Morphometry - Within Group Comparison — 4.18; 3.27; 3.85; 3.76 peak voxel z-score
N/A N=1,173 Three Strategies for Implementing Motivational Interviewing on Medical Inpatient Units
See One · Do One · Order One
Primary: Percentage of Motivation Interviewing Sessions Audio Recorded — 0.8; 3.0; 20.5 percentage of MI sessions audio recorded — p=0.0009
N/A N=70 PrEP Readiness Interventions for Supporting Motivation
HIV Infections · Pre-exposure Prophylaxis · Substance Use Disorders
Primary: Proportion of Participants Filling a Prescription for PrEP — 0; 2; 2; 5 Participants
N/A N=44 Targeted Self-Management for Epilepsy and Serious Mental Illness (TIME)
Epilepsy · Schizophrenia · Schizoaffective Disorder
Primary: Change in Montgomery Asberg Depression Rating Scale (MADRS) — 16.75; 22.94; 11.21; 21.81 score on a scale — p=0.036
N/A N=31 Novel and Scalable Internet Supplemented Weight Loss Treatment in Primary Care
Overweight · Obesity
Primary: Body Weight in Pounds — 207.4 pounds
N/A N=29 Goal Elicitation, Treatment Prioritization, & Electronically-Practiced Discussion for Psychiatry
Mental Illness · Shared Decision Making
Primary: Patient Activation Measure for Mental Health (PAM-MH) — 59.8; 61.6 units on a scale
Phase 2 N=217 Intensive Motivational Interviewing for Methamphetamine Dependence
Methamphetamine Dependence
Primary: Methamphetamine Days of Abstinence : Proportion of Days Abstinent — .56; .55; .74; .74 proportion of days abstinent — p=.47
N/A N=71 Pilot Study of Motivational Interviewing for Loved Ones
Psychotic Disorders · Psychosis · Psychotic Episode
Primary: Change in the Number of Mental Health Related Appointments Attended by the Individual With Psychosis (IP) in the Past 30 Days — 0.29; -1.06 number of appointments
N/A N=29 Auricular Acupuncture For The Treatment Of Non-Epileptic Seizures
Convulsion, Non-Epileptic
Primary: Completion Rate of Auricular Acupuncture in Patients With NES — 15 Participants
N/A N=356 Peer Online Motivational Interviewing for Sexual and Gender Minority Male Survivors
Sexual Abuse
Primary: Number of Participants Who Engage in Mental Health Treatment — 23; 18; 31; 26 Participants
N/A N=510 MOTIVATional intErviewing to Improve Self-care in Heart Failure Patients
Heart Failure
Primary: Self-care Maintenance in Patients — 52.36; 54.23; 49.63 score on a scale
N/A N=63 Primary Care Treatment Integrating Motivation and Exposure
Stress Disorders, Post-Traumatic · Alcohol-Related Disorders
Primary: Change in Clinician Administered PTSD Scale (CAPS)-5 Severity Rating — 28.46; 33.45 score on a scale
N/A N=75 Motivational Interview Intervention to Help Patients Formulate Their Goals for Medical Care in the Emergency Department
Emergency Service, Hospital · Motivational Interviewing · Advance Care Planning
Primary: Number of Patients Who Found the Intervention Acceptable and Provided Suggestions for Improvement — 48 Participants
N/A N=40 Motivational Interviewing for Weight Loss
Childhood Obesity
Primary: Weight Efficacy Life-style Questionnaire — 120.70; 128.80; 139.88; 136.40 scores on a scale — p=0.24
N/A N=79 Motivational Negative Symptoms in Schizophrenia: Intervention and Biomarkers
Schizophrenia · Schizoaffective Disorder
Primary: Strauss-Carpenter Level of Function Scale — 97.69; 94.56 score on a scale
N/A N=8 Motivation Skills Training for Schizophrenia
Schizophrenia · Schizoaffective Disorder
Primary: Change in Motivation and Pleasure Scale (MAP) — 0.50 score on a scale
N/A N=180 Impact of Group Motivational Interviewing and In-Home-Messaging-Devices for Dually Diagnosed Veterans
Alcohol Dependence · Dual Diagnosis · Drug Dependence
Primary: Number of Alcohol Drinking Days in the Previous 30 (One Month Follow up) and 60 (Three Month Follow up) Days — 5.1; 6.5; 6.7; 8.8 Days Using Alcohol — p=<0.01
N/A N=200 Engaging Older Adults in Fall Prevention Using Motivational Interviewing (MI)
Fall · Motivation · Behavior
Primary: Falls Self-Efficacy Scale-International (FES-I) Results — 13.07; 13.71; 13.41; 14.35 units on a scale — p=<0.05
N/A N=195 Effects of Adding Motivational Interviewing to Antidepressant Treatment for Hispanic Adults With Depression
Depression
Primary: Number of Days in ADT (Retention) — 59.5; 65.5; 148.7; 164.1 Days in treatment — p=0.26
Phase 1 N=50 Motivational Interviewing to Improve Medication Adherence Among Hispanic Adults With Depression
Depression
Primary: Medication Adherence, as Measured by Electronic Pill Container — 58.76; 34.7 Percentage of Days — p=<.05
Phase 4 N=69 Anxiety and Depression in Epilepsy: A Treatment Study
Anxiety · Depression · Epilepsy
Primary: Adherence to Intervention — 2; 0; 0 Participants
N/A N=94 TAKE Steps: Motivational Interviewing to Prevent STIs
Self Efficacy · HIV Prevention · STI Prevention
Primary: Change in Prevention Self-efficacy — 1.87; 0.20 score on a scale — p=0.04